PDL BioPharma Inc. (Nasdaq: PDLI) was removed from the S&P MidCap 400 index after it spun off its biotechnology busines into a separate unit sending the stock price plummeting $2.25 to close at $6.75.
PDL BioPharma Removed From S&P MidCap 400
December 19, 2008 at 17:24 PM EST
